- Home
- CHNR vs NTBL Comparison
CHNR vs NTBL Comparison
Compare CHNR & NTBL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CHNR
- NTBL
- Stock Information
- Founded
- CHNR N/A
- NTBL 2000
- Country
- CHNR Hong Kong
- NTBL United States
- Employees
- CHNR N/A
- NTBL N/A
- Industry
- CHNR Precious Metals
- NTBL Biotechnology: Pharmaceutical Preparations
- Sector
- CHNR Basic Materials
- NTBL Health Care
- Exchange
- CHNR Nasdaq
- NTBL Nasdaq
- Market Cap
- CHNR 6.4M
- NTBL 4.6M
- IPO Year
- CHNR 1995
- NTBL N/A
- Fundamental
- Price
- CHNR $0.79
- NTBL $0.34
- Analyst Decision
- CHNR
- NTBL Buy
- Analyst Count
- CHNR 0
- NTBL 2
- Target Price
- CHNR N/A
- NTBL $5.00
- AVG Volume (30 Days)
- CHNR 148.0K
- NTBL 8.0M
- Earning Date
- CHNR 01-01-0001
- NTBL 11-12-2024
- Dividend Yield
- CHNR N/A
- NTBL N/A
- EPS Growth
- CHNR N/A
- NTBL N/A
- EPS
- CHNR N/A
- NTBL N/A
- Revenue
- CHNR N/A
- NTBL $313,000.00
- Revenue This Year
- CHNR N/A
- NTBL N/A
- Revenue Next Year
- CHNR N/A
- NTBL N/A
- P/E Ratio
- CHNR N/A
- NTBL N/A
- Revenue Growth
- CHNR N/A
- NTBL 3812.50
- 52 Week Low
- CHNR $0.55
- NTBL $0.22
- 52 Week High
- CHNR $8.85
- NTBL $4.24
- Technical
- Relative Strength Index (RSI)
- CHNR 53.35
- NTBL 43.04
- Support Level
- CHNR $0.68
- NTBL $0.28
- Resistance Level
- CHNR $0.83
- NTBL $0.67
- Average True Range (ATR)
- CHNR 0.10
- NTBL 0.06
- MACD
- CHNR -0.00
- NTBL -0.00
- Stochastic Oscillator
- CHNR 24.60
- NTBL 27.53
About CHNR China Natural Resources Inc.
China Natural Resources Inc is an investment holding company. It principally engaged in the exploration and mining and wastewater treatment businesses in the People's Republic of China. The company has two operating segments: (i) Wastewater treatment segment, which consists of sales of assembled equipment, provision of construction service, and participation in PPP projects as an operator (ii) Exploration and mining segment, which consists of the exploration of lead, silver, and other metals in the Inner Mongolia Autonomous Region of the PRC and the trading of copper ores products. It earns the majority of its revenue from the Wastewater treatment segment.
About NTBL Notable Labs Ltd.
Notable Labs Ltd is a clinical-stage platform therapeutics company developing predictive precision medicines for patients with cancer. Through its proprietary Predictive Precision Medicines Platform (PPMP), Notable bio-simulates a cancer treatment to predict whether or not a patient is likely to respond to that specific therapeutic. PPMP is designed to enable Notable to identify and select patients expected to be clinically responsive before the initiation of their treatment and potentially enable fast-track therapeutic development in this patient population.